Share this article and save a life!
For my non-radiology colleagues, which nodule is which is worrisome? A or B? Lung cancer found early, 10mm or less, improves long-term survival, per Dr. Henschke’s most recent study.
“What we present here is the 20-year follow-up on participants in our screening program that were diagnosed with lung cancer and subsequently treated,” Dr. Claudia Henschke of Icahn School of Medicine at Mount Sinai
“The key finding is that even after this long a time interval they are not dying of their lung cancer.”
The study found that the 20-year survival rate was 80% for the 1,285 I-ELCAP participants who were diagnosed with early-stage lung cancer. The survival rate for both the 139 participants with nonsolid cancerous lung nodules and the 155 participants with nodules of part-solid consistency was 100%.
For the 991 participants with solid nodules, the survival rate was 73%. Lung cancer survival for clinical Stage IA participants was 86%, regardless of consistency. For participants with pathologic Stage IA cancers of 10 mm or less, the 20-year survival rate was 92%.
The findings demonstrate the importance of routine and early screening.
“Ultimately, anyone interested in being screened needs to know that if they are unfortunate enough to develop lung cancer, that it can be cured if found early,” Dr. Henschke said.
For those of you playing along, A is the worrisome nodule with the spiculated margins.
A=Malignant, cancer
B=Benign, probably a lymph node
Improving lung cancer screening efficiency and compliance for all patients is the Oatmeal Health mission. With a new #HEDIS measure on the horizon from NCQA, we would like to help FQHCs be prepared.
We are ready to help. Please send ty@oatmealhealth.com a note if you’d like to learn more about Oatmeal Health.
#primarycare #radiology #lungcancerscreening #FQHC
Link to #RSNA article: https://lnkd.in/g6XpWh2d
Radiological Society of North America (RSNA)
Co-Authors:
David Yankelevitz, M.D.
Daniel M. Libby
James Smith, M.D.
Mark Pasmantier, M.D.
Rowena Yip, MPH
Share this article and save a life!
Author:
Jonathan is a seasoned executive with a proven track record in founding and scaling digital health and technology companies. He co-founded Oatmeal Health, a tech-enabled Cancer Screening as a Service for Underrepresented patients of FQHCs and health plans, starting with lung cancer. With a strong background in engineering, partnerships, and product development, Jonathan is recognized as a leader in the industry.
Govette has dedicated his professional life to enhancing the well-being of marginalized populations. To achieve this, he has established frameworks for initiatives aimed at promoting health equity among underprivileged communities.
